| 000 | 01045 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250516152311.0 | ||
| 264 | 0 | _c20131113 | |
| 008 | 201311s 0 0 eng d | ||
| 022 | _a1527-3792 | ||
| 024 | 7 |
_a10.1016/j.juro.2013.05.041 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLogothetis, Christopher J | |
| 245 | 0 | 0 |
_aTreatment of castrate-resistant prostate cancer. _h[electronic resource] |
| 260 |
_bThe Journal of urology _cAug 2013 |
||
| 300 |
_a439-40 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Comment | ||
| 650 | 0 | 4 |
_aAndrogen Antagonists _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunotherapy _xmethods |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
| 773 | 0 |
_tThe Journal of urology _gvol. 190 _gno. 2 _gp. 439-40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.juro.2013.05.041 _zAvailable from publisher's website |
| 999 |
_c22780502 _d22780502 |
||